Journal Article

Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity

Sarah J. Tabrizi, Michael Orth, J. Max Wilkinson, Jan-Willem Taanman, Thomas T. Warner, J. Mark Cooper and Anthony H.V. Schapira

in Human Molecular Genetics

Volume 9, issue 18, pages 2683-2689
Published in print November 2000 | ISSN: 0964-6906
Published online November 2000 | e-ISSN: 1460-2083 | DOI: http://dx.doi.org/10.1093/hmg/9.18.2683
Expression of mutant α-synuclein causes increased susceptibility to dopamine toxicity

Show Summary Details

Preview

Mutations of the α-synuclein gene have been identified in autosomal dominant Parkinson’s disease (PD). Transgenic mice overexpressing wild-type human α-synuclein develop motor impairments, intraneuronal inclusions and loss of dopaminergic terminals in the striatum. To study the mechanism of action through which mutant α-synuclein toxicity is mediated, we have generated stable, inducible cell models expressing wild-type or PD-associated mutant (G209A) α-synuclein in human-derived HEK293 cells. Increased expression of either wild-type or mutant α-synuclein resulted in the formation of cytoplasmic aggregates which were associated with the vesicular (including monoaminergic) compartment. Expression of mutant α-synuclein induced a significant increase in sensitivity to dopamine toxicity compared with the wild-type protein expression. These results provide an explanation for the preferential dopaminergic neuronal degeneration seen in both the PD G209A mutant α-synuclein families and suggest that similar mechanisms may underlie or contribute to cell death in sporadic PD.

Journal Article.  4438 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.